News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Merck & Co., Inc. (JOBS) Loses Effort to Dismiss 24 Fosamax Cases
September 10, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- A Manhattan federal judge has rejected Merck & Co's effort to dismiss 24 cases alleging that its Fosamax drug treatment for osteoporosis causes jaw damage.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Merck & Co.
MORE ON THIS TOPIC
Government
Trump’s CDC Pick Says Vaccines Are Safe, Promises To Keep Them Available
June 26, 2025
·
2 min read
·
Tristan Manalac
Vaccines
RFK Cuts U.S. Funding From Vaccine Alliance Gavi, Claims Group ‘Ignored the Science’
June 26, 2025
·
2 min read
·
Tristan Manalac
Vaccines
What To Watch for as ACIP’s New Era Begins
June 25, 2025
·
3 min read
·
Dan Samorodnitsky
Immunology and inflammation
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced
June 25, 2025
·
3 min read
·
Tristan Manalac